ArticleCureus2026
Olfactory Groove Meningioma Mimicking Late-Life Depression: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Late-life depression presenting with atypical features, progressive functional decline, behavioral changes, or poor response to treatment should prompt consideration of secondary causes. Olfactory groove meningiomas are slow-growing anterior skull base tumors that may remain clinically silent for prolonged periods and may present primarily with neuropsychiatric symptoms due to frontal lobe involvement. We report the case of a 64-year-old woman with a progressive depressive presentation characterized by marked functional decline, apathy, abulia, behavioral disinhibition, impaired insight, and executive dysfunction. Symptoms were initially interpreted as a primary depressive disorder in the context of bereavement and were poorly responsive to psychopharmacological treatment. Neuroimaging revealed a large extra-axial anterior skull base mass centered on the olfactory groove, measuring approximately 63 mm in maximum diameter, with homogeneous contrast enhancement, marked mass effect on the frontal lobes, and extensive vasogenic edema. The patient underwent surgical resection in January 2024. Histopathological examination confirmed a World Health Organization grade 2 olfactory groove meningioma, with brain invasion and spontaneous necrosis. Postoperative imaging showed a small probable residual lesion, and the patient subsequently underwent adjuvant radiotherapy with 60 Gy in 30 fractions using volumetric modulated arc therapy. Follow-up imaging demonstrated a slight reduction in the residual lesion. Clinically, the patient showed postoperative improvement, with preserved orientation and language functions, no focal neurological deficits, and a return to functional independence in daily life, although residual anosmia and non-specific orthostatic symptoms persisted. This case illustrates a strong clinical association between a large olfactory groove meningioma and a late-life neuropsychiatric presentation initially interpreted as depression. Such tumors should be considered when apparent late-life depression is accompanied by progressive functional deterioration, behavioral disinhibition, impaired insight, executive dysfunction, or poor response to adequate psychiatric treatment. Neuroimaging should be considered in these presentations to identify potentially treatable structural brain lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.